Form 4: Ralph Alvarez Buys Eli Lilly Stock

Director Ralph Alvarez acquired 16.833 shares of Eli Lilly & Co common stock at $698.05 per share on August 18, 2025.

Summary

• Ralph Alvarez, a director of Eli Lilly & Co, acquired 16.833 shares of common stock.
• The transaction occurred on August 18, 2025.
• The price per share was $698.05.
• Following the transaction, Alvarez directly owns 55,011.413 shares of common stock.
• Alvarez also indirectly owns 758 shares through a trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a standard transaction by a director, with no explicit positive or negative implications.

Positives

• Director's purchase may signal confidence in the company's future.
• Increased direct ownership of common stock by the director.

Future Outlook

Shares acquired are deferred as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Management Comments

• The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and prospects.

Comparison to Industry Standards

• Comparing insider trading activity to peers such as Pfizer (PFE) and Johnson & Johnson (JNJ) can provide a broader context.
• Benchmarking the director's stock ownership against industry averages for board members can offer insights into alignment with shareholder interests.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the director's increased investment in the company.

Key Dates

Recommendation

The purchase is a relatively small amount of stock and is part of a deferred compensation plan. It does not provide enough information to change a recommendation.

Keywords

Eli Lilly, LLY, Ralph Alvarez, Director, Stock Acquisition, SEC Form 4, Beneficial Ownership